{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:10:32Z","timestamp":1784203832682,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.toxlet.2017.07.879","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T04:03:36Z","timestamp":1499832216000},"page":"16-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231"],"prefix":"10.1016","volume":"279","author":[{"given":"Luba","family":"Hunakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Brtko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2017.07.879_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0973-1482.154071","article-title":"The combined effects of all-trans-retinoic acid and docosahexaenoic acid on the induction of apoptosis in human breast cancer MCF-7 cells","volume":"12","author":"Abdolahi","year":"2016","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drudis.2009.02.002","article-title":"Organometallic compounds in oncology: implications of novel organotins as antitumor agents","volume":"14","author":"Alama","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0009-2797(00)00249-0","article-title":"Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride","volume":"134","author":"Barbieri","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00001813-200207000-00006","article-title":"Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models","volume":"13","author":"Barbieri","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1097-0320(19991101)37:3<191::AID-CYTO5>3.0.CO;2-U","article-title":"Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate","volume":"37","author":"Bartkowiak","year":"1999","journal-title":"Cytometry"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.toxlet.2015.02.009","article-title":"Triorganotin compounds\u2014ligands for rexinoid inducible transcription factors: biological effects","volume":"234","author":"Brtko","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0035","first-page":"329","article-title":"Nuclear retinoid X receptors and their endogenous or triorganotin-based ligands in metabolism, differentiation and organism development","volume":"16","author":"Brtko","year":"2016","journal-title":"Int. Med."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0040","doi-asserted-by":"crossref","first-page":"R546","DOI":"10.1186\/bcr913","article-title":"A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands","volume":"6","author":"Crowe","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0045","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1038\/sj.onc.1206485","article-title":"Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1\/PI 3-kinase\/AKT pathway","volume":"22","author":"del Rinc\u00f3n","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0055","first-page":"6","article-title":"A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (\u2212)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines","volume":"85308","author":"Farabegoli","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0060","first-page":"2642","article-title":"Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status","volume":"57","author":"Fitzgerald","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.toxlet.2014.09.030","article-title":"Proteomic analysis of changes in the protein composition of MCF-7 human breast cancer cells induced by all-trans retinoic acid, 9-cis retinoic acid, and their combination","volume":"232","author":"Flodrova","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/taap.2000.9076","article-title":"Organotins induce apoptosis by disturbance of [Ca(2 +)](i) and mitochondrial activity, causing oxidative stress and activation of caspases in rat thymocytes","volume":"169","author":"Gennari","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0075","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1007\/s13277-015-4524-6","article-title":"Anticancer effects of tributyltin chloride and triphenyltin chloride in human breast cancer cell lines MCF-7 and MDA-MB-231","volume":"37","author":"Hunakova","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0080","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/mc.22232","article-title":"Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells","volume":"54","author":"Kim","year":"2015","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0085","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1248\/bpb.b212017","article-title":"Molecular mechanisms of environmental organotin toxicity in mammals","volume":"35","author":"Kotake","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.240590802","article-title":"Retinoids and chemoprevention: clinical and basic studies","volume":"22","author":"Lippman","year":"1995","journal-title":"J. Cell. Biochem. Suppl."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0095","first-page":"2415","article-title":"Retinoids and their receptors in modulation of differentiation development, and prevention of head and neck cancers","volume":"16","author":"Lotan","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0100","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1471::AID-CNCR1>3.0.CO;2-6","article-title":"The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer","volume":"83","author":"Miller","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.steroids.2016.02.008","article-title":"Retinoid N-(1H-benzo[d]imidazol-2-yl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide induces p21-dependent senescence in breast cancer cells","volume":"108","author":"Mumcuoglu","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00204-002-0428-5","article-title":"Metabolism of tributyltin and triphenyltin by rat, hamster and human hepatic microsomes","volume":"77","author":"Ohhira","year":"2003","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0120","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1038\/sj.onc.1207956","article-title":"Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK","volume":"23","author":"Pettersson","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/erc.0.0100261","article-title":"How to target estrogen receptor-negative breast cancer?","volume":"10","author":"Rochefort","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.toxlet.2017.07.879_bib0130","first-page":"6549","article-title":"9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein","volume":"54","author":"Rubin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcb.240530417","article-title":"Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR\u03b1 gene expression and sensitivity to growth inhibition by retinoic acid","volume":"53","author":"Sheikh","year":"1993","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0140","doi-asserted-by":"crossref","first-page":"21440","DOI":"10.1016\/S0021-9258(17)31823-9","article-title":"Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids","volume":"269","author":"Sheikh","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0145","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jorganchem.2005.12.033","article-title":"Chemical and biotechnological developments in organotin cancer chemotherapy","volume":"691","author":"Tabassum","year":"2006","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0150","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1158\/0008-5472.CAN-08-4407","article-title":"Therapeutic potential of \"Rexinoids\" in cancer prevention and treatment","volume":"69","author":"Tanaka","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxlet.2016.05.005","article-title":"Radioligand binding assay for accurate determination of nuclear retinoid X receptors: a case of triorganotin endocrine disrupting ligands","volume":"254","author":"Toporova","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-642-10858-7_13","article-title":"Chemoprevention of hormone receptor-negative breast cancer: new approaches needed","volume":"188","author":"Uray","year":"2011","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0303-7207(93)90267-N","article-title":"Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function","volume":"91","author":"van der Burg","year":"1993","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.toxlet.2017.07.879_bib0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/excr.1997.3589","article-title":"Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells","volume":"234","author":"Zhu","year":"1997","journal-title":"Exp. Cell Res."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417311165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417311165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T20:06:03Z","timestamp":1659211563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427417311165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":34,"alternative-id":["S0378427417311165"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.07.879","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.07.879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}